Patents by Inventor Gregg Homer

Gregg Homer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11931295
    Abstract: A method for altering an eye color of a patient with a color alteration procedure is disclosed that may include imaging the iris with an image sensor prior to the color alteration procedure to generate an image of the iris. A mapping of the iris may be generated from the image. The mapping may include a number of regions corresponding to varying absorption coefficients of a treatment wavelength in the stromal pigment of the iris. A laser system may be set, based on the mapping, to deliver laser light at a laser power sufficient to cause elimination of at least a portion of stromal pigment in the iris. The laser light may then be delivered with the laser system.
    Type: Grant
    Filed: January 7, 2022
    Date of Patent: March 19, 2024
    Assignee: STROMA MEDICAL CORPORATION
    Inventor: Gregg Homer
  • Publication number: 20240058171
    Abstract: A method for altering an eye color of a patient with a color alteration procedure is disclosed that may include determining a laser power to deliver to stromal pigment in an iris of the eye of the patient by at least retrieving a set of laser criteria for delivery of an exposure less than 100 times a maximum permissible exposure that causes elimination of at least a portion of the stromal pigment. A laser system may be set to deliver laser light at the laser power which is less than the set of laser criteria and the laser light may be delivered with the laser system.
    Type: Application
    Filed: October 16, 2023
    Publication date: February 22, 2024
    Inventor: Gregg HOMER
  • Patent number: 11896527
    Abstract: A system for supporting and aligning a patient during a color alteration procedure includes a laser system that delivers a laser in a first direction. A control computer may be adjacent the laser system for controlling the laser system. The control computer system may include a user interface in a first plane substantially perpendicular to the first direction. The system may include a patient support structure having a patient support surface extending in a second direction substantially perpendicular to the first direction and configured to be adjustable to set a patient position or alignment relative to the laser system. Coarse adjustment hardware may be configured to cause automated and/or manual adjustments to the patient support surface in the first direction. Fine adjustment hardware may be configured to cause automated fine adjustments to the patient support surface in the first direction based on instructions received from the control computer.
    Type: Grant
    Filed: January 10, 2022
    Date of Patent: February 13, 2024
    Assignee: STROMA MEDICAL CORPORATION
    Inventor: Gregg Homer
  • Publication number: 20240009030
    Abstract: Rather than rely solely upon pupillary occlusion or tracking of eye movement to protect the fundus from accidental exposure to electromagnetic radiation, the present invention also utilizes an electromagnetic radiation pathway with a profile such that the energy density at the iris is greater than the energy density at the posterior portion of the eye. This disparity in energy density allows for efficacy at the anterior iris treatment site, without injury to the fundus.
    Type: Application
    Filed: September 19, 2023
    Publication date: January 11, 2024
    Inventor: Gregg HOMER
  • Patent number: 11819458
    Abstract: A method for altering an eye color of a patient with a color alteration procedure is disclosed that may include determining a laser power to deliver to stromal pigment in an iris of the eye of the patient by at least retrieving a set of laser criteria for delivery of an exposure less than 100 times a maximum permissible exposure that causes elimination of at least a portion of the stromal pigment. A laser system may be set to deliver laser light at the laser power which is less than the set of laser criteria and the laser light may be delivered with the laser system.
    Type: Grant
    Filed: October 21, 2021
    Date of Patent: November 21, 2023
    Assignee: STROMA MEDICAL CORPORATION
    Inventor: Gregg Homer
  • Patent number: 11806282
    Abstract: Rather than rely solely upon pupillary occlusion or tracking of eye movement to protect the fundus from accidental exposure to electromagnetic radiation, the present invention also utilizes an electromagnetic radiation pathway with a profile such that the energy density at the iris is greater than the energy density at the posterior portion of the eye. This disparity in energy density allows for efficacy at the anterior iris treatment site, without injury to the fundus.
    Type: Grant
    Filed: April 28, 2022
    Date of Patent: November 7, 2023
    Assignee: STROMA MEDICAL CORPORATION
    Inventor: Gregg Homer
  • Publication number: 20220354697
    Abstract: Rather than rely solely upon pupillary occlusion or tracking of eye movement to protect the fundus from accidental exposure to electromagnetic radiation, the present invention also utilizes an electromagnetic radiation pathway with a profile such that the energy density at the iris is greater than the energy density at the posterior portion of the eye. This disparity in energy density allows for efficacy at the anterior iris treatment site, without injury to the fundus.
    Type: Application
    Filed: April 28, 2022
    Publication date: November 10, 2022
    Applicant: Stroma Medical Corporation
    Inventor: Gregg Homer
  • Publication number: 20220304850
    Abstract: A method for altering an eye color of a patient with a color alteration procedure is disclosed that may include imaging the iris with an image sensor prior to the color alteration procedure to generate an image of the iris. A mapping of the iris may be generated from the image. The mapping may include a number of regions corresponding to varying absorption coefficients of a treatment wavelength in the stromal pigment of the iris. A laser system may be set, based on the mapping, to deliver laser light at a laser power sufficient to cause elimination of at least a portion of stromal pigment in the iris. The laser light may then be delivered with the laser system.
    Type: Application
    Filed: January 7, 2022
    Publication date: September 29, 2022
    Applicant: Stroma Medical Corporation
    Inventor: Gregg HOMER
  • Publication number: 20220304851
    Abstract: A system for altering the eye color of a patient with a color alteration procedure includes a laser system having a housing around at least one component of the laser system. The laser system also has a perimeter circuit configured to detect a breach of the housing based on the perimeter circuit being broken resulting in an electrical current flowing through the perimeter circuit being ceased or a change in resistance in the perimeter circuit. The system also includes software that detects, by the perimeter circuit, the breach based on the perimeter circuit being broken. The software also executes, based on the breach, an electronic lockout of the laser system such that the laser system cannot be operated without receipt of a command lifting the electronic lockout.
    Type: Application
    Filed: January 7, 2022
    Publication date: September 29, 2022
    Applicant: Stroma Medical Corporation
    Inventor: Gregg Homer
  • Publication number: 20220304857
    Abstract: A method for altering an eye color of a patient with a color alteration procedure is disclosed that may include determining a laser power to deliver to stromal pigment in an iris of the eye of the patient by at least retrieving a set of laser criteria for delivery of an exposure less than 100 times a maximum permissible exposure that causes elimination of at least a portion of the stromal pigment. A laser system may be set to deliver laser light at the laser power which is less than the set of laser criteria and the laser light may be delivered with the laser system.
    Type: Application
    Filed: October 21, 2021
    Publication date: September 29, 2022
    Applicant: Stroma Medical Corporation
    Inventor: Gregg Homer
  • Publication number: 20220304852
    Abstract: A system for supporting and aligning a patient during a color alteration procedure includes a laser system that delivers a laser in a first direction. A control computer may be adjacent the laser system for controlling the laser system. The control computer system may include a user interface in a first plane substantially perpendicular to the first direction. The system may include a patient support structure having a patient support surface extending in a second direction substantially perpendicular to the first direction and configured to be adjustable to set a patient position or alignment relative to the laser system. Coarse adjustment hardware may be configured to cause automated and/or manual adjustments to the patient support surface in the first direction. Fine adjustment hardware may be configured to cause automated fine adjustments to the patient support surface in the first direction based on instructions received from the control computer.
    Type: Application
    Filed: January 10, 2022
    Publication date: September 29, 2022
    Applicant: Stroma Medical Corporation
    Inventor: Gregg HOMER
  • Publication number: 20220265470
    Abstract: The present invention predicts prior to a laser iris color-change procedure what a patient's iris color will be after the procedure. The present invention does so by identifying and measuring a variety of anatomical features of the patient's eye that affect or are otherwise relevant to predicting the patient's post-operative iris color, translating these measurements into a post-operative iris color prediction, and communicating this prediction to the patient in a manner sufficient to manage the patient's expectations with respect to the aesthetic outcome of the procedure.
    Type: Application
    Filed: May 4, 2022
    Publication date: August 25, 2022
    Applicant: Stroma Medical Corporation
    Inventor: Gregg HOMER
  • Publication number: 20220249280
    Abstract: Rather than rely solely upon pupillary occlusion or tracking of eye movement to protect the fundus from accidental exposure to electromagnetic radiation, the present invention also utilizes an electromagnetic radiation pathway with a profile such that the energy density at the iris is greater than the energy density at the posterior portion of the eye. This disparity in energy density allows for efficacy at the anterior iris treatment site, without injury to the fundus.
    Type: Application
    Filed: April 28, 2022
    Publication date: August 11, 2022
    Applicant: Stroma Medical Corporation.
    Inventor: Gregg HOMER
  • Publication number: 20220192871
    Abstract: Rather than rely solely upon pupillary occlusion or tracking of eye movement to protect the fundus from accidental exposure to electromagnetic radiation, the present invention also utilizes an electromagnetic radiation pathway with a profile such that the energy density at the iris is greater than the energy density at the posterior portion of the eye. This disparity in energy density allows for efficacy at the anterior iris treatment site, without injury to the fundus.
    Type: Application
    Filed: January 11, 2022
    Publication date: June 23, 2022
    Applicant: Stroma Medical Corporation
    Inventor: Gregg HOMER
  • Patent number: 11357666
    Abstract: The present invention predicts prior to a laser iris color-change procedure what a patient's iris color will be after the procedure. The present invention does so by identifying and measuring a variety of anatomical features of the patient's eye that affect or are otherwise relevant to predicting the patient's post-operative iris color, translating these measurements into a post-operative iris color prediction, and communicating this prediction to the patient in a manner sufficient to manage the patient's expectations with respect to the aesthetic outcome of the procedure.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: June 14, 2022
    Assignee: Stroma Medical Corporation
    Inventor: Gregg Homer
  • Patent number: 11278452
    Abstract: A method for altering an eye color of a patient with a color alteration procedure is disclosed that may include imaging the iris with an image sensor prior to the color alteration procedure to generate an image of the iris. A mapping of the iris may be generated from the image. The mapping may include a number of regions corresponding to varying absorption coefficients of a treatment wavelength in the stromal pigment of the iris. A laser system may be set, based on the mapping, to deliver laser light at a laser power sufficient to cause elimination of at least a portion of stromal pigment in the iris. The laser light may then be delivered with the laser system.
    Type: Grant
    Filed: April 22, 2021
    Date of Patent: March 22, 2022
    Assignee: Stroma Medical Corporation
    Inventor: Gregg Homer
  • Patent number: 11273074
    Abstract: A system for altering the eye color of a patient with a color alteration procedure includes a laser system having a housing around at least one component of the laser system. The laser system also has a perimeter circuit configured to detect a breach of the housing based on the perimeter circuit being broken resulting in an electrical current flowing through the perimeter circuit being ceased or a change in resistance in the perimeter circuit. The system also includes software that detects, by the perimeter circuit, the breach based on the perimeter circuit being broken. The software also executes, based on the breach, an electronic lockout of the laser system such that the laser system cannot be operated without receipt of a command lifting the electronic lockout.
    Type: Grant
    Filed: April 22, 2021
    Date of Patent: March 15, 2022
    Assignee: Stroma Medical Corporation
    Inventor: Gregg Homer
  • Patent number: 11259962
    Abstract: A system for supporting and aligning a patient during a color alteration procedure includes a laser system that delivers a laser in a first direction. A control computer may be adjacent the laser system for controlling the laser system. The control computer system may include a user interface in a first plane substantially perpendicular to the first direction. The system may include a patient support structure having a patient support surface extending in a second direction substantially perpendicular to the first direction and configured to be adjustable to set a patient position or alignment relative to the laser system. Coarse adjustment hardware may be configured to cause automated and/or manual adjustments to the patient support surface in the first direction. Fine adjustment hardware may be configured to cause automated fine adjustments to the patient support surface in the first direction based on instructions received from the control computer.
    Type: Grant
    Filed: April 22, 2021
    Date of Patent: March 1, 2022
    Assignee: Stroma Medical Corporation
    Inventor: Gregg Homer
  • Patent number: 11160685
    Abstract: A method for altering an eye color of a patient with a color alteration procedure is disclosed that may include determining a laser power to deliver to stromal pigment in an iris of the eye of the patient by at least retrieving a set of laser criteria for delivery of an exposure less than 100 times a maximum permissible exposure that causes elimination of at least a portion of the stromal pigment. A laser system may be set to deliver laser light at the laser power which is less than the set of laser criteria and the laser light may be delivered with the laser system.
    Type: Grant
    Filed: April 22, 2021
    Date of Patent: November 2, 2021
    Assignee: Stroma Medical Corporation
    Inventor: Gregg Homer
  • Publication number: 20200206026
    Abstract: The present invention predicts prior to a laser iris color-change procedure what a patient's iris color will be after the procedure. The present invention does so by identifying and measuring a variety of anatomical features of the patient's eye that affect or are otherwise relevant to predicting the patient's post-operative iris color, translating these measurements into a post-operative iris color prediction, and communicating this prediction to the patient in a manner sufficient to manage the patient's expectations with respect to the aesthetic outcome of the procedure.
    Type: Application
    Filed: August 16, 2017
    Publication date: July 2, 2020
    Inventor: Gregg Homer